Research News

Transcriptional repression by a secondary DNA binding surface of DNA topoisomerase I safeguards against hypertranscription

A team of scientists, led by N2CR member Dr. Tee Wee Wei, has identified the enzyme DNA topoisomerase I (TOP1) as a key regulator of gene activity crucial for normal development and health. Their discovery reveals that a specific disease-associated mutation (R548Q) in TOP1 accelerates gene activity, disrupting normal developmental programs. Tight control of gene activity is essential, as dysregulation can contribute to diseases, particularly in aggressive cancers characterized by transcriptional overdrive. Importantly, the mutation does not impact TOP1’s primary enzymatic function but hinders its ability to bind to DNA correctly. This research highlights TOP1 as a molecular rheostat, ensuring precise control of gene activity levels and maintaining appropriate total transcription levels in our cells.

Read more here: https://www.nature.com/articles/s41467-023-42078-9

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

New Book by Prof Goh Boon Cher & A/Prof Wang Lingzhi

We are pleased to share that Prof. Goh Boon Cher and A/Prof. Wang Lingzhi have published a new edited volume …

Read More →
Research News

New Hope for Treating Drug-Resistant Leukaemia

Acute myeloid leukaemia (AML) is a fast-growing blood cancer that often becomes resistant to standard treatments. This resistance is linked …

Read More →
Research News

Prospective Evaluation of QPOP in Relapsed/ Refractory Non-Hodgkin’s Lymphoma

Treatment of relapsed/refractory non-Hodgkin’s lymphoma (R/R-NHL) remains one of the most difficult challenges in haematologic malignancies, with many patients exhausting …

Read More →